{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:40:15Z","timestamp":1756287615883,"version":"3.44.0"},"reference-count":5,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,10,26]]},"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1136\/bcr-2019-232536","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T07:25:20Z","timestamp":1573802720000},"page":"e232536","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["The dilemma of whether to continue TNF\u03b1 blocker therapy in an ulcerative colitis patient newly diagnosed with a malignant melanoma and melanoma in situ"],"prefix":"10.1136","volume":"12","author":[{"given":"Louise","family":"Zuzarte","sequence":"first","affiliation":[{"name":"Jephson Dermatology Center, South Warwickshire NHS Foundation Trust, Warwick, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Mirhadi","sequence":"additional","affiliation":[{"name":"Jephson Dermatology Center, South Warwickshire NHS Foundation Trust, Warwick, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A","family":"Carr","sequence":"additional","affiliation":[{"name":"Department of Histopathology, South Warwickshire NHS Foundation Trust, Warwick, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9221-7618","authenticated-orcid":false,"given":"Simon","family":"Tso","sequence":"additional","affiliation":[{"name":"Jephson Dermatology Center, South Warwickshire NHS Foundation Trust, Warwick, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"key":"2025082701584825000_12.11.e232536.1","first-page":"195","article-title":"Development of primary malignant melanoma during treatment with a TNF-\u03b1 antagonist for severe Crohn\"s disease: a case report and review of the hypothetical association between TNF-\u03b1 blockers and cancer","volume":"7","author":"Kouklakis","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"2025082701584825000_12.11.e232536.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.027"},{"key":"2025082701584825000_12.11.e232536.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.12.024"},{"key":"2025082701584825000_12.11.e232536.4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.05.004"},{"key":"2025082701584825000_12.11.e232536.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.04.033"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-232536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:58:58Z","timestamp":1756285138000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-232536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":5,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,14]]},"published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1136\/bcr-2019-232536"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-232536","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}